Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The trial, called SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes)-6, involved about 3,000 patients and compared semaglutide, as well as other GLP-1 RAs, with a placebo
Despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose in this population
Excess adipose tissue produces estrogen through aromatization of androgens, disrupting the hypothalamic-pituitary-gonadal axis
Expanding treatment options is an important step forward, but continued advocacy and awareness are essential to ensure more people can benefit
Yes, if youre currently using Ozempic for weight loss, it is recommended that you switch to Wegovy
Healthline Gao, R., Tao, Y., & Zhou, C
